Download 3rd International Conference on Cutaneous Lupus (ICCLE) Agenda

3rd International Conference on Cutaneous Lupus (ICCLE)
Agenda
Scotland - May 6 - 8, 2013
Satellite meeting of the International Investigative Dermatology Conference
Surgeons' Hall
Edinburgh, Scotland, UK
May 6-8, 2013
About the Conference
International Investigative Dermatology 2013 (IID 2013) is the five-yearly scientific meeting of the European Society
for Dermatological Research, Society for Investigative Dermatology and Japanese Society for Investigative
Dermatology and includes several pre- and post-satellite meetings. Approximately 2,000 delegates attend the
meeting which combine prestigious guest lectures, plenary and concurrent sessions, sponsored symposia, poster
presentations, a rich educational program and more.
The ICCLE conference, which is conducted in English, is a scientific meeting on Cutaneous Lupus Erythematosus
and related autoimmune diseases. This satellite meeting of the International Investigative Dermatology conference
will bring together researchers, clinicians, young scientists and residents to assess the state-of-the-art, discuss
controversy and present new data. It will lay important groundwork for further developments in the field.
May 6, 2013 (Monday)
9:00-9:10 Opening remarks
Pathogenesis of CLE and DM
Moderators: Jan Dutz and Fukumi Furukawa
Lupus



9:10-9:40 Animal models of interface dermatitis, (Dutz)
9:40-10:10 Trex1 in CHLE (Lee-Kirsch)
10:10-10:40 Antimicrobial peptides in CLE (Gläser)
10:40-11:00 Break and Poster viewing
Dermatomyositis



11:00-11:30 Autoantibodies in DM (Fiorentino)
11:30-12:00 Japanese studies with autoantibodies (Manubo Fujimoto)
12:00-12:30 Animal models of myositis (Okiyama)
Lunch 12:30-1:15 and Poster viewing
Definition and Diagnosis of lupus
Moderators: Filippa Nyberg and Jörg Wenzel
Lupus





1:15-1:30 Introduction of approach (Werth)
1:30-1:45 Delphi approach: history (Merola)
1:45-2:15 Diagnostic vs classification criteria; and current definition and diagnostic
criteria of CLE (Connolly)
2:15-2:45 Histology of CLE (Wenzel)
2:45-3:15 Definition of CLE/SLE vs CLE (Chong)
3:15-3:30 Break
3:30-3:45 Consensus related to definitions and diagnosis of CLE (Nyberg)
4:00-6:00 (small groups)




How do we want to define CLE
List of all potential cutaneous lupus subsets
Which criteria would be best to diagnose the different subtypes of CLE? (morphologic,
serologic, histologic, other clinical features)
Is there a need for a borderline form between CLE and SLE?
Dinner on your own
Tuesday, May 7
8:30-8:45 Report of small groups for definition and diagnosis
8:45-9:15 Synthesis: (Nyberg)
Epidemiology
Moderators: Thomas Ruzicka and Mark Davis
Lupus


9:15-9:45 Population based incidence/prevalence of CLE in US (Mark Davis)
9:45-10:15 Subtypes of lupus in Asia (Furukawa)
10:15-10:45 Break
10:45-11:30 Poster Viewing (presenters at their posters)


11:30-12:00 Epidemiology of CLE: incidence, prevalence, medications, cancer (Nyberg)
12:00-12:20 EUSCLE update, including Core Set Questionnaire (Kuhn)
Lunch 12:20-1:00
Dermatomyositis
Moderators: Mark Goodfield and David Fiorentino



1:00-1:30 Population based incidence of DM (Davis)
1:30-2:00 Lung disease and DM (Ang)
2:00-2:30 Cancer and DM (Hasegawa)

2:30-3:00 QoL in CLE and DM (Verma)
Break 3:00-3:15
Classification (CLE, CLE/SLE, SLE, DM)
Moderator: Lela Lee and Annegret Kuhn
Lupus



3:15-3:45 Current categorizations of CLE and lupus-nonspecific skin lesions; (Costner)
3:45-3:55 Dusseldorf Classification of CLE (Kuhn)
3:55-4:25 Classification criteria for SLE (Zoma)
Discussion:
Potential Categorization of of lupus specific and lupus nonspecific skin lesions (Lela Lee)
(4:25-4:40)
4:40-6:00 (small groups)



What is the purpose of the groupings of CLE subtypes?
Do we need a new way to group subtypes of CLE, e.g. of LE-specific and LE-nonspecific manifestations
What should these groupings look like?
Dinner
Wednesday, May 8
8-8:15 In memorium of Thomas Provost (Sontheimer)
8:15-8:45 small group leaders presentation
8:45-9:30 Synthesis (Lela Lee)
9:30-10:15 Discussion about next steps
Dermatomyositis
Moderators: Sontheimer


10:15-10:45 Amyopathic DM and classification (Sontheimer)
10:45-11:15 Classification criteria for DM (Lundberg)
Break 11:15-11:30
Treatment
Moderators: Werth and Szepietowski
Lupus






11:30-11:45 Treatment of CLE (Jessop)
11:45-12:00 Impact of smoking (Meggitt)
12:00-12:15 Vitamin D and lupus (Wittmann)
12:15-12:30 Topical treatment in CLE (Ruzicka)
12:30-12:45 Use of antimalarials (Frances)
12:45-1:00 Thalidomide and Lenalidomide (Ordi Ros)
1:00-1:45 Lunch




1:45-2:00 Dapsone and retinoids (Aberer)
2:00-2:15 Stem Cell Therapy and LE (Goodfield)
2:15-2:30 New clinical treatments in CLE (Werth)
2:30-2:45 Current practice variations in cutaneous lupus therapy and thoughts about
international guidelines (Szepietowski)
Dermatomyositis

2:45-3:00 Treatment of dermatomyositis (Volc-Platzer)